亚太地区转染试剂和设备市场预测至 2030 年 - 区域分析 - 按产品(试剂和仪器)、方法(病毒方法、非病毒方法和混合方法)、应用(生物医学研究、蛋白质生产和治疗递送)和最终用户(学术和研究机构以及制药和生物技术公司)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 122    |    Report Code: BMIRE00030389    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Transfection Reagents and Equipment Market
2022 年亚太地区转染试剂和设备市场价值为 2.2223 亿美元,预计到 2030 年将达到 4.1429 亿美元;预计 2022 年至 2030 年的复合年增长率为 8.1%。

癌症经济负担加重推动亚太地区转染试剂和设备市场发展

根据世界卫生组织 (WHO) 的数据,癌症是全球主要死亡原因之一,2020 年导致约 1000 万人死亡。根据国际癌症研究机构的数据,到 2040 年全球癌症负担可能会增加 3020 万例。根据乳腺癌组织的数据,全球约 5-10% 的乳腺癌病例是遗传性的,是由世代相传的异常基因引起的。根据 2023 年发表在《国际流行病学杂志》上的《生活方式、遗传风险和癌症发病率》一文,近 33% 的癌症是遗传性的,并且该疾病的基因突变风险很高。因此,人们选择进行基因分析,以便及早发现和个性化治疗遗传性癌症病例。BRCA1 和 BRCA2 有时被称为肿瘤抑制基因。继承了这些基因之一的有害变异的人患上几种癌症的风险更大,其中最明显的是乳腺癌和卵巢癌等。与没有上述基因变异的人相比,这些人也往往在更年轻的时候患上癌症。专注于癌细胞核酸加工的研究可能有助于了解癌症代谢。DNA 通常被包装成病毒或非病毒颗粒,以转移到要转染的细胞中。基因转移已被提议作为一种新方法来增强抗肿瘤药物在治疗难治性或转移性癌症方面的有效性。据报道,基因治疗和药物(类似疗法)的结合可增强传统治疗对肺癌、结直肠癌、胰腺癌、膀胱癌和乳腺癌等的抗增殖作用。因此,癌症经济负担的增加推动了亚太地区转染试剂和设备市场的发展。

亚太地区转染试剂和设备市场概览

亚太地区分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。中国在 2022 年拥有最大的市场份额。中国、印度、新加坡等亚太国家拥有完善的医疗保健体系以及快速发展的制药和医疗行业。这些国家有许多医疗机构为癌症患者提供治疗和护理服务。根据美国国立卫生研究院的一项研究,2010 年至 2020 年期间,中国癌症医院每年的患者入院人数从 110 万增加到 324 万。根据 2023 年《美国医学会杂志》发表的一项研究,中国大陆 18 岁及以上人群的慢性肾病 (CKD) 患病率为 8.2%。此外,国际癌症研究机构 (IARC) 的最新数据表明,中国胃癌的估计年龄标准化率 (ASR) 为每 100,000 人 21 人,粗率为 33.06;胰腺癌的 ASR 为每 100,000 人 5 人,粗率为 8.6。根据同一来源,2020 年 0-74 岁人群(男女)胃癌和胰腺癌新发病例估计数分别为 478,508 例和 124,994 例。因此,慢性病的高负担推动了中国对 CGT 的需求,进而推动了转染试剂和设备市场的增长。

亚太地区转染试剂和设备市场收入及预测至 2030 年(百万美元)

亚太地区转染试剂和设备市场细分

亚太地区转染试剂和设备市场根据产品、方法、应用、最终用户和国家/地区进行细分。

根据产品,亚太地区转染试剂和设备市场分为试剂和仪器。试剂部分在 2022 年占有较大份额。

就方法而言,亚太地区转染试剂和设备市场分为病毒方法、非病毒方法和混合方法。非病毒方法部分在 2022 年占有最大份额。病毒部分细分为逆转录病毒、腺病毒、腺相关病毒和疱疹病毒。非病毒部分分为物理/机械方法和化学方法。此外,物理/机械方法部分细分为电穿孔、显微注射、基因枪法、激光法、磁转染和声穿孔。此外,化学方法部分细分为基于脂质体/高脂质和非基于脂质体/高脂质。

按应用,亚太地区转染试剂和设备市场细分为生物医学研究、蛋白质生产和治疗输送。生物医学研究部门在 2022 年占有最大份额。

根据最终用户,亚太地区转染试剂和设备市场分为学术和研究机构以及制药和生物技术公司。学术和研究机构部门在 2022 年占有较大份额。

根据国家/地区,亚太地区转染试剂和设备市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。 2022 年,中国在亚太转染试剂和设备市场占据主导地位。

Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc 和 Polyplus-Transfection SA 是亚太转染试剂和设备市场的一些领先公司。

Asia Pacific Transfection Reagents and Equipment Strategic Insights

Strategic insights for Asia Pacific Transfection Reagents and Equipment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-transfection-reagents-and-equipment-market-strategic-framework.webp
Get more information on this report

Asia Pacific Transfection Reagents and Equipment Report Scope

Report Attribute Details
Market size in 2022 US$ 222.23 Million
Market Size by 2030 US$ 414.29 Million
Global CAGR (2022 - 2030) 8.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 试剂及仪器
By 方法
  • 病毒方法
  • 非病毒方法
  • 混合方法
By 最终用户
  • 学术机构
  • 研究机构以及制药和生物技术公司
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Get more information on this report

    Asia Pacific Transfection Reagents and Equipment Regional Insights

    The regional scope of Asia Pacific Transfection Reagents and Equipment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-transfection-reagents-and-equipment-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Transfection Reagents and Equipment Market

    1. Thermo Fisher Scientific Inc
    2. Promega Corp
    3. F. Hoffmann-La Roche Ltd
    4. Bio-Rad Laboratories Inc
    5. Mirus Bio LLC
    6. QIAGEN NV
    7. Merck KGaA
    8. Lonza Group AG
    9. MaxCyte Inc

    Frequently Asked Questions
    How big is the Asia Pacific Transfection Reagents and Equipment Market?

    The Asia Pacific Transfection Reagents and Equipment Market is valued at US$ 222.23 Million in 2022, it is projected to reach US$ 414.29 Million by 2030.

    What is the CAGR for Asia Pacific Transfection Reagents and Equipment Market by (2022 - 2030)?

    As per our report Asia Pacific Transfection Reagents and Equipment Market, the market size is valued at US$ 222.23 Million in 2022, projecting it to reach US$ 414.29 Million by 2030. This translates to a CAGR of approximately 8.1% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Transfection Reagents and Equipment Market report typically cover these key segments-

  • 产品 (试剂及仪器)
  • 方法 (病毒方法, 非病毒方法, 混合方法)
  • 最终用户 (学术机构, 研究机构以及制药和生物技术公司)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Transfection Reagents and Equipment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Transfection Reagents and Equipment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Transfection Reagents and Equipment Market?

    The Asia Pacific Transfection Reagents and Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Who should buy this report?

    The Asia Pacific Transfection Reagents and Equipment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Transfection Reagents and Equipment Market value chain can benefit from the information contained in a comprehensive market report.